Split History
QLTI split history picture
QLTI (QLTI) has 1 split in our QLTI split history database. The split for QLTI took place on October 13, 1999. This was a 2 for 1 split, meaning for each share of QLTI owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as QLTI splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the QLTI split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into QLTI shares, starting with a $10,000 purchase of QLTI, presented on a split-history-adjusted basis factoring in the complete QLTI split history. QLTI split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 10/01/2012
End date: 11/29/2016
Start price/share: $7.67
End price/share: $1.95
Starting shares: 1,303.78
Ending shares: 2,466.49
Dividends reinvested/share: $3.92
Total return: -51.90%
Average Annual Total Return: -16.12%
Starting investment: $10,000.00
Ending investment: $4,809.33
Years: 4.16
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/01/2012
End date: 11/29/2016
Start price/share: $7.67
End price/share: $1.95
Dividends collected/share: $3.92
Total return: -23.53%
Average Annual Total Return: -6.24%
Starting investment: $10,000.00
Ending investment: $7,646.64
Years: 4.16
QLT is a biotechnology company engaged in the development and commercialization of ocular products. Co.'s operations consist of clinical development programs focused on its synthetic retinoid, QLT091001, for the treatment of certain age-related and inherited retinal diseases caused by retinal pigment epithelium protein 65 and lecithin: retinol acyltransferase gene mutations, which indication includes Leber Congenital Amaurosis and Retinitis Pigmentosa. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle. According to our QLTI split history records, QLTI has had 1 split.
Date Ratio
10/13/19992 for 1
QLTI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

RARE Split History
RCKT Split History
RCPI Split History
RDNT Split History
RDY Split History
REPH Split History
RGLS Split History
RHE Split History
RMD Split History
RMTI Split History

Email EnvelopeFree QLTI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

QLTI Insider Buying

QLTI Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.